Beigene (ONC) Competitors

Beigene (NASDAQ:ONC) and GSK (NYSE:GSK) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Do insiders & institutionals have more ownership in ONC or GSK?

48.5% of Beigene shares are held by institutional investors. Comparatively, 15.7% of GSK shares are held by institutional investors. 7.4% of Beigene shares are held by insiders. Comparatively, 10.0% of GSK shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts recommend ONC or GSK?

Beigene presently has a consensus price target of $327.00, indicating a potential upside of 30.88%. GSK has a consensus price target of $43.25, indicating a potential upside of 11.28%. Given Beigene's stronger consensus rating and higher possible upside, equities analysts clearly believe Beigene is more favorable than GSK.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beigene	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
GSK	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	3 Strong Buy rating(s)	2.60

Does the media favor ONC or GSK?

In the previous week, GSK had 21 more articles in the media than Beigene. MarketBeat recorded 32 mentions for GSK and 11 mentions for Beigene. GSK's average media sentiment score of 0.39 beat Beigene's score of 0.32 indicating that GSK is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beigene	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GSK	16 Very Positive mention(s)	0 Positive mention(s)	12 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Is ONC or GSK more profitable?

GSK has a net margin of 8.13% compared to Beigene's net margin of -25.94%. GSK's return on equity of 48.59% beat Beigene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beigene	-25.94%	-25.12%	-14.95%
GSK	8.13%	48.59%	11.11%

Which has preferable earnings & valuation, ONC or GSK?

GSK has higher revenue and earnings than Beigene. Beigene is trading at a lower price-to-earnings ratio than GSK, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beigene	$3.81B	6.42	-$881.71M	-$6.14	-40.69
GSK	$31.38B	2.57	$3.29B	$1.59	24.44

Does the MarketBeat Community believe in ONC or GSK?

GSK received 819 more outperform votes than Beigene when rated by MarketBeat users. However, 75.00% of users gave Beigene an outperform vote while only 57.12% of users gave GSK an outperform vote.

Company	Underperform	Outperform
Beigene	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%
GSK	Outperform Votes 822 57.12%	Underperform Votes 617 42.88%

Which has more risk and volatility, ONC or GSK?

Beigene has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, GSK has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Summary

GSK beats Beigene on 12 of the 19 factors compared between the two stocks.